METTL3 and non-small cell lung carcinoma: In a study by Jin et al. (2019), METTL3 increased m6A modification of Yes-associated protein (YAP)-encoding mRNA and MALAT1 lncRNA, which induced resistance to cisplatin and metastasis in the NSCLC cells [88].